SPY760.07+0.39%QQQ692.70+0.66%BTC/USD71,231.50−0.20%DIA523.75+0.24%GLD355.55+0.19%TLT79.59−0.16%

Oscar Health Inc

OSCRNYSE

Trade with Public

$31.94

-0.17-0.53%

Last update: Nov 12, 6:34 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Oscar Health (OSCR) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Oscar Health (OSCR) stock.

Analyst Consensus — 9 Analysts

5Buy

2Hold

2Sell

# Analysts9

Latest Upgrades and Downgrades for Oscar Health Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Piper Sandler	Jessica Tassan	PT Cut	Overweight	$48→$45
—	UBS	Jonathan Yong	PT Raise	Neutral	$26→$36
—	Raymond James	John Ransom	PT Raise	Outperform	$34→$42
—	B of A Securities	Adam Ron	PT Raise	Underperform	$28→$30
—	Stephens & Co.	Raj Kumar	Maintained	Equal-Weight	$34
—	Barclays	Andrew Mok	PT Raise	Overweight	$39→$49
—	Baird	Michael Ha	PT Raise	Neutral	$27→$33
—	Wells Fargo	Stephen Baxter	PT Raise	Equal-Weight	$20→$27
—	UBS	Jonathan Yong	PT Raise	Neutral	$20→$26
—	Barclays	Andrew Mok	PT Raise	Overweight	$35→$39
—	Barclays	Andrew Mok	Upgrade	Equal-Weight→Overweight	$30→$35
—	Barclays	Andrew Mok	PT Raise	Equal-Weight	$21→$30
—	UBS	Jonathan Yong	PT Raise	Neutral	$15→$20
—	Barclays	Andrew Mok	PT Raise	Equal-Weight	$18→$21
—	Baird	Michael Ha	PT Raise	Neutral	$15→$19
—	Wolfe Research	Justin Lake	Initiate	Peer Perform	—
—	Jefferies	David Windley	Upgrade	Underperform→Hold	$10→$16
—	UBS	Jonathan Yong	Upgrade	Sell→Neutral	$12→$17
—	Barclays	Andrew Mok	Upgrade	Underweight→Equal-Weight	$13→$18
—	Stephens & Co.	Dean Sublett	Initiate	Equal-Weight	$17

Oscar Health Inc

Oscar Health (OSCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Oscar Health Stock

Oscar Health (OSCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Oscar Health Stock

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PRO
UBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRO
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PRO
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PRO
Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PRO
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PRO
UBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRO
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PRO
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PRO
Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PRO
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49

Oscar Health Inc

Oscar Health (OSCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Oscar Health Stock

Oscar Health (OSCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Oscar Health Stock

Analyst Ratings News

PROPiper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PROUBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRORaymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PROB of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PROStephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PROBarclays Maintains Overweight on Oscar Health, Raises Price Target to $49

People Also Watch

People Also Watch

Analyst Ratings News

PROPiper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PROUBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRORaymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PROB of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PROStephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PROBarclays Maintains Overweight on Oscar Health, Raises Price Target to $49

PRO
Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PRO
UBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRO
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PRO
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PRO
Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PRO
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49

PRO
Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45

PRO
UBS Maintains Neutral on Oscar Health, Raises Price Target to $36

PRO
Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

PRO
B of A Securities Maintains Underperform on Oscar Health, Raises Price Target to $30

PRO
Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

PRO
Barclays Maintains Overweight on Oscar Health, Raises Price Target to $49